Sort
40,608 grants matching “prostate cancer”
Planning to implement high-quality active surveillance in new-onset favorable risk prostate cancer
$327,496Anne Evelyn Sales · University Of Missouri-Columbia · R34 · FY2024 · CA
Community Outreach Program
$327,456Daniel Blumenthal · Morehouse School Of Medicine · U54 · FY2014 · CA
Equol and Regulation of Prostate Growth
$327,445Robert J Handa · University Of Arizona · R01 · FY2008 · CA
Implementation of phosphoprotein preservation technology for cancer biospecimens
$327,438Lance A Liotta · George Mason University · R33 · FY2011 · CA
Development of a Molecular Targeting Agent for PSMA to Diagnose Metastatic Prosta
$327,410James F Kronauge · Molecular Insight Pharmaceuticals, Inc. · R44 · FY2011 · CA
DEVELOPMENT OF ANTICANCER 1, 2-BIS(SULFONYL) HYDRAZINES
$327,409Yale University · R01 · FY2003 · CA
DEVELOPMENT OF ANTICANCER 1, 2-BIS(SULFONYL) HYDRAZINES
$327,409Yale University · R01 · FY2002 · CA
Functional Imaging of the Metastatic Phenotype
$327,409Johns Hopkins University · R01 · FY2005 · CA
Functional Imaging of the Metastatic Phenotype
$327,409Johns Hopkins University · R01 · FY2004 · CA
DEVELOPMENT OF ANTICANCER 1, 2-BIS(SULFONYL) HYDRAZINES
$327,409Yale University · R01 · FY2004 · CA
Functional Imaging of the Metastatic Phenotype
$327,409Johns Hopkins University · R01 · FY2003 · CA
Functional Imaging of the Metastatic Phenotype
$327,409Johns Hopkins University · R01 · FY2002 · CA
The Role of AKT in Prostate Cancer
$327,393William R Sellers · Beth Israel Deaconess Medical Center · P01 · FY2009 · CA
A CLINICAL TRIAL WITH FINASTERIDE AND SELENIUM
$327,349James Marshall · Roswell Park Cancer Institute Corp · P01 · FY2008 · CA
Small Molecule Antibody Mimics: Toward a New Paradigm in Targeted Cancer Therapy
$327,334David Adam Spiegel · Yale University · R01 · FY2015 · GM
Project 1 - Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in neuroendocrine prostate cancer
$327,334Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
Improving Biopsies using Magnetic Nanoparticles
$327,296Edward R Flynn · Senior Scientific · R44 · FY2009 · CA
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancer
$327,253Jong Y Park · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
Identifying Disparities in Mild Cognitive Impairment and Alzheimer's Disease and Related Dementias in Diverse Prostate Cancer Survivors
$327,239Brian D Gonzalez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Novel glutamate conjugates for radiotargeting PSMA
$327,235Molecular Insight Pharmaceuticals, Inc. · R43 · FY2004 · EB
Mechanism of promiscuous AR activation in PTEN-mutated prostate cancer
$327,228Haojie Huang · Mayo Clinic Rochester · R01 · FY2015 · CA
KGF IN PROSTATE CANCER--A TRANSGENIC ANIMAL MODEL
$327,215Baylor College Of Medicine · R01 · FY2002 · CA
Project 2 - Clinical translation
$327,209Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2019 · CA
Project 1- Role of fat in metastatic engraftment and expansion in the liver
$327,163Neil A Bhowmick · Cedars-Sinai Medical Center · P01 · FY2021 · CA
WUMC-Cancer and Leukemia Group B
$327,143Washington University · U10 · FY2005 · CA